CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 39,653	$ 19,570	$ 10,210
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	5,086	3,231	3,444
Inventory obsolescence reserve	281	399	359
Amortization of deferred issuance costs	496	361	109
Stock-based compensation	1,186	711	13,687
Loss on extinguishment of debt			716
Change in common stock warrant fair value			3,425
Change in interest rate cap fair value	(435)
Unrecognized tax benefits	(1,199)	743	1,670
Deferred income taxes	557	4,454	(3,923)
Net provision for doubtful accounts	(31)	17	(27)
Loss on disposal of fixed assets		10	1
Changes in operating assets and liabilities:
Accounts receivable	(211)	(551)	(286)
Inventories	(2,754)	1,193	(2,086)
Prepaid expenses and other current assets	(763)	(658)	3,348
Income tax receivable		5	(5)
Other assets	39	45	(45)
Accounts payable	2,847	(2,104)	(1,697)
Income tax payable	(75)	(328)	884
Accrued expenses and other current liabilities	4,720	(866)	963
Net cash provided by operating activities	49,397	26,232	30,747
CASH FLOWS FROM INVESTING ACTIVITIES:
Disposal of assets	96
Payment for acquisition, net of cash acquired	(80,511)
Purchases of property and equipment	(5,305)	(4,135)	(3,817)
Net cash used in investing activities	(85,720)	(4,135)	(3,817)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock			91,071
Proceeds from issuance of long-term debt	80,832		50,000
Payments of costs directly associated with offerings		(449)	(7,202)
Cash paid for withholding taxes on vested stock	(78)	(4)
Excess tax benefits		312
Principal payments on long-term debt	(39,320)	(14,865)	(71,250)
Proceeds from revolving line of credit			9,208
Payments on revolving line of credit		(3,126)	(14,271)
Repurchase and retirement of common stock			(4,502)
Payments of debt discount			(923)
Payments of deferred issuance costs	(1,240)	0	(300)
Dividends paid			(79,945)
Proceeds from exercise of common stock warrant			90
Net cash provided by (used in) financing activities	40,194	(18,132)	(28,024)
NET CHANGE IN CASH AND CASH EQUIVALENTS	3,871	3,965	(1,094)
CASH AND CASH EQUIVALENTS — BEGINNING OF PERIOD	4,038	73	1,167
CASH AND CASH EQUIVALENTS — END OF PERIOD	7,909	4,038	73
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash payments for interest	2,976	2,006	397
Cash payments for income taxes	13,549	$ 6,541	9,635
SIGNIFICANT NON-CASH INVESTING AND FINANCING ACTIVITIES:
Capital expenditures in accounts payable and accrued expenses	$ 733
Payment of costs directly associated with the issuance of common stock			2,107
Issuance of shares of common stock warrants			$ 12,572